Belépés

NCT03146156Befejeződött

Lifestyle Intervention in Preparation for Pregnancy (LIPP)

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. okt. 8.

Rövid összefoglaló (regiszter, angolul)

Studies evaluating lifestyle intervention in obese women during pregnancy have reported limited success in decreasing excessive gestational weight gain, and have failed to achieve the key outcome of breaking the obesity cycle and reducing neonatal adiposity or birth weight. Although some investigators advocate weight loss during pregnancy in obese women, these recommendations were based on extrapolation of retrospective epidemiological data. Of concern, we reported increased small for gestational age babies and decreased lean body mass in neonates of obese women with weight loss or inadequate gestational weight gain. Based on our research, optimal outcomes from lifestyle interventions are likely to be temporal and therefore must be initiated prior to conception to first improve maternal metabolic function, and subsequently, placental/fetal growth. Several large retrospective cohort studies support our hypothesis. For example, women who lost weight between pregnancies had fewer large for gestational age babies in contrast to women who increased interpregnancy weight. In addition, prospective randomized controlled trials have shown that postpartum weight loss is achievable without adverse maternal or neonatal outcomes, these studies include women who breastfed. Based on these observations, we propose a randomized control trial to determine the effect of lifestyle intervention initiated prior to a planned pregnancy on improving neonatal metabolism and adiposity. Our overarching hypothesis is that the maternal pre-pregnancy metabolic condition determines the obesogenic in-utero environment, which affects programming of placental mitochondrial function and metabolic pathways, promoting lipid accumulation and neonatal adiposity. Our rationale is based on the need to establish the most effective time to introduce an intervention that will break the obesity cycle in mothers and their children. Understanding how pregravid metabolic conditioning improves maternal physiology, and cellular and molecular function in pregnancy will provide the empirical data to support the intervention. We have a highly successful record of recruiting women who are planning a pregnancy, obtaining compliance in longitudinal studies, and in long-term follow-up of mothers and their offspring. Lifestyle intervention will be initiated prior to conception to decrease maternal body fat, inflammation, insulin resistance, and ?-cell dysfunction. Our transdisciplinary team has the required expertise in lifestyle interventions management of obesity, and in human physiology that is needed to determine the effects of these interventions on maternal metabolism and fetalplacental growth and function. We will recruit 200 women to pursue the following specific aims: Specific Aim 1: To investigate the physiological significance of lifestyle intervention in preparation for pregnancy (LIPP) on maternal and neonatal metabolism and adiposity. Specific Aim 2: To determine the molecular effects whereby lifestyle intervention initiated before pregnancy can improve placental mitochondrial lipid oxidation and accumulation.

Állapot (regiszter)
Befejeződött
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
143 (tényleges)
Első benyújtás
2017. márc. 22.
Kezdés
2017. márc. 21.
Elsődleges befejezés
2025. aug. 31.
Fő szponzor
Tufts Medical Center
Betegségek
Elhízás
NCT-szám
NCT03146156

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó
  • Bevont résztvevők: 143
  • 2017. márc. 21. és az elsődleges befejezés (2025. aug. 31.) között
  • 4 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálatot írja le, nem a te helyzetedet.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Korábbi kezelés

  • asthma requiring more than occasional use of a sympathomimetic inhaler, but not chronic inhaled steroids
  • Tobacco, excessive alcohol use (greater than 2 drinks/day) or illicit drug use
  • Gastric surgery to lose weight including banding or bypass procedures
  • If a LIPP subject becomes pregnant prior to 16 weeks after randomization before the weight- loss phase for the lifestyle intervention is completed or a control subject becomes pregnant before the 3 month postpartum randomization, i.e. no baseline measurement.

Más betegség

  • Pre or post-delivery diabetes
  • Post-delivery hypertension requiring medication
  • Inflammatory bowel disease
  • Eating disorders such as bulimia
  • Any psychological or psychiatric condition which may impair participation in the lifestyle intervention program
  • HIV, or hepatitis B or C

Egyéb

  • Need for assisted reproductive technologies to become pregnant
  • Medical or obstetrical contraindication to the defined exercise program or diet
  • Multiple pregnancy

Kiket keres a vizsgálat

  • All subjects will have had by the time of randomization at 3 months postpartum:
  • Planning another pregnancy within the next 24 months
  • Planning to deliver at Tufts medical center during their next pregnancy
  • A previous full-term singleton pregnancy (gestational age \> 37 weeks)
  • 18 to 40 years of age at the time of enrollment into the study
  • Vaginal or cesarean delivery
  • Normal glucose tolerance or gestational diabetes (GDM), but without evidence of postpartum diabetes as defined by a 75 g 2-hr oral glucose tolerance test (OGTT)
  • Normal blood pressure or mild preeclampsia but normal postpartum blood pressure
  • Bottle or breast feeding
  • Normal thyroid function (determined by TSH concentration in blood), normal cell blood count and normal kidney and liver functions. Lipid profile with triglyceride levels not higher than 400 mg/dl (fasting) and LDL levels less than 180 mg/dL
  • No clinical signs or symptoms of cardiovascular disease or any other disease or condition that may contraindicate participation in exercise training (i.e. COPD, severe asthma, orthopedic abnormalities)
  • Using contraception

Életkor a regiszterben: 18 év – 40 év · Nem: csak nők · Egészséges önkénteseket is fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (4)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Pennington Biomedical Research Center
Ennek a helyszínnek vagy a koordinátora? Erősítsd meg az állapotát
Baton RougeEgyesült ÁllamokIsmeretlen állapot
Tufts Medical Center
Ennek a helyszínnek vagy a koordinátora? Erősítsd meg az állapotát
BostonEgyesült ÁllamokIsmeretlen állapot
Brigham and Women's Hospital
Ennek a helyszínnek vagy a koordinátora? Erősítsd meg az állapotát
BostonEgyesült ÁllamokIsmeretlen állapot
MetroHealth Medical Center
Ennek a helyszínnek vagy a koordinátora? Erősítsd meg az állapotát
ClevelandEgyesült ÁllamokIsmeretlen állapot

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.